These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 71873)

  • 1. The macrophage electrophoretic mobility (MEM) test for the diagnosis of hydatidiform mole and choriocarcinoma. Preliminary report.
    Klausch B; Straube W; Hofmann R; Büttner HH; Jenssen HL; Köhler H; Günther J
    Ann Chir Gynaecol; 1977; 66(4):209-13. PubMed ID: 71873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry in the diagnosis of the gestational trophoblastic disease.
    Lösch A; Kainz C
    Acta Obstet Gynecol Scand; 1996 Sep; 75(8):753-6. PubMed ID: 8906012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational trophoblastic disease. A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma.
    Brewer JI; Eckman TR; Dolkart RE; Torok EE; Webster A
    Am J Obstet Gynecol; 1971 Jan; 109(2):335-40. PubMed ID: 5539127
    [No Abstract]   [Full Text] [Related]  

  • 5. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA; Tatarinov IuS; Iugrinova LG; Olefirenko GA; Dotsenko IuS
    Vopr Onkol; 1981; 27(12):19-23. PubMed ID: 6275607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity in the MEM-test of cancer patients' lymphocytes incubated with brain-derived preparations and extracts from malignant teratomas.
    Müller M; Irmscher J; Grossmann H; Kotzsch M; Wagner H; Kemmer C
    Arch Geschwulstforsch; 1981; 51(4):354-63. PubMed ID: 6172087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
    Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
    Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on molar pregnancy and choriocarcinoma.
    Ilancheran A; Singh P
    Singapore Med J; 1989 Oct; 30(5):473-5. PubMed ID: 2694375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the radioreceptor assay for human chorionic gonadotropin in pregnancy testing and management of trophoblastic disease.
    Boyko WL; Russell HT
    Obstet Gynecol; 1977 Sep; 50(3):324-32. PubMed ID: 197458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnosis of trophoblastic tumours from uterine curettings.
    Elston CW; Bagshawe KD
    J Clin Pathol; 1972 Feb; 25(2):111-8. PubMed ID: 4335992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY; Saxena BB; Landesman R
    Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
    J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choriocarcinoma and partial hydatidiform moles.
    Seckl MJ; Fisher RA; Salerno G; Rees H; Paradinas FJ; Foskett M; Newlands ES
    Lancet; 2000 Jul; 356(9223):36-9. PubMed ID: 10892763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological and hormono-metabolic indices in trophoblastic disease].
    Poroshina TE; Semenovskiĭ AV; Bobrov IuF; Gamaiunova VB; Ostroumova MN
    Vopr Onkol; 1987; 33(10):57-61. PubMed ID: 2825428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.